Global Qingkailing Injection Market Growth 2026-2032

January 2026 | 91 pages | ID: GA5571081D97EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Qingkailing Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Qingkailing injection is a compound preparation of traditional Chinese medicine; it has the effects of clearing away heat and detoxifying, resolving phlegm and unblocking meridians, refreshing the mind and invigorating the orifices; it is used for fever, coma, hemiplegia caused by stroke, and mental confusion; it is clinically used for the treatment of patients with the above symptoms such as acute hepatitis, upper respiratory tract infection, pneumonia, cerebral thrombosis, and cerebral hemorrhage.

United States market for Qingkailing Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Qingkailing Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Qingkailing Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Qingkailing Injection players cover Yabao Pharmaceutical Group Co., Ltd., Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd., Shanxi Taihang Pharmaceutical Co., Ltd., Henan Province Shennong Pharmaceutical Co., Ltd., Guangdong Leiyunshang Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Qingkailing Injection Industry Forecast? looks at past sales and reviews total world Qingkailing Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Qingkailing Injection sales for 2026 through 2032. With Qingkailing Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Qingkailing Injection industry.

This Insight Report provides a comprehensive analysis of the global Qingkailing Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Qingkailing Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Qingkailing Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Qingkailing Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Qingkailing Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Qingkailing Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 2ml Each
  • 10ml Each
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Yabao Pharmaceutical Group Co., Ltd.
  • Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd.
  • Shanxi Taihang Pharmaceutical Co., Ltd.
  • Henan Province Shennong Pharmaceutical Co., Ltd.
  • Guangdong Leiyunshang Pharmaceutical Co., Ltd.
  • Shenwei Pharmaceutical Group Co., Ltd.
  • Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Qingkailing Injection market?
What factors are driving Qingkailing Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Qingkailing Injection market opportunities vary by end market size?
How does Qingkailing Injection break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Qingkailing Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Qingkailing Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Qingkailing Injection by Country/Region, 2021, 2025 & 2032
2.2 Qingkailing Injection Segment by Type
  2.2.1 2ml Each
  2.2.2 10ml Each
  2.2.3 Qingkailing Injection Sales by Type
    2.2.3.1 Global Qingkailing Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Qingkailing Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Qingkailing Injection Sale Price by Type (2021-2026)
2.3 Qingkailing Injection Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Qingkailing Injection Sales by Application
    2.3.4.1 Global Qingkailing Injection Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Qingkailing Injection Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Qingkailing Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Qingkailing Injection Breakdown Data by Company
  3.1.1 Global Qingkailing Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Qingkailing Injection Sales Market Share by Company (2021-2026)
3.2 Global Qingkailing Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Qingkailing Injection Revenue by Company (2021-2026)
  3.2.2 Global Qingkailing Injection Revenue Market Share by Company (2021-2026)
3.3 Global Qingkailing Injection Sale Price by Company
3.4 Key Manufacturers Qingkailing Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Qingkailing Injection Product Location Distribution
  3.4.2 Players Qingkailing Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR QINGKAILING INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Qingkailing Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Qingkailing Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Qingkailing Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Qingkailing Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Qingkailing Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Qingkailing Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Qingkailing Injection Sales Growth
4.4 APAC Qingkailing Injection Sales Growth
4.5 Europe Qingkailing Injection Sales Growth
4.6 Middle East & Africa Qingkailing Injection Sales Growth

5 AMERICAS

5.1 Americas Qingkailing Injection Sales by Country
  5.1.1 Americas Qingkailing Injection Sales by Country (2021-2026)
  5.1.2 Americas Qingkailing Injection Revenue by Country (2021-2026)
5.2 Americas Qingkailing Injection Sales by Type (2021-2026)
5.3 Americas Qingkailing Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Qingkailing Injection Sales by Region
  6.1.1 APAC Qingkailing Injection Sales by Region (2021-2026)
  6.1.2 APAC Qingkailing Injection Revenue by Region (2021-2026)
6.2 APAC Qingkailing Injection Sales by Type (2021-2026)
6.3 APAC Qingkailing Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Qingkailing Injection by Country
  7.1.1 Europe Qingkailing Injection Sales by Country (2021-2026)
  7.1.2 Europe Qingkailing Injection Revenue by Country (2021-2026)
7.2 Europe Qingkailing Injection Sales by Type (2021-2026)
7.3 Europe Qingkailing Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Qingkailing Injection by Country
  8.1.1 Middle East & Africa Qingkailing Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Qingkailing Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Qingkailing Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Qingkailing Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Qingkailing Injection
10.3 Manufacturing Process Analysis of Qingkailing Injection
10.4 Industry Chain Structure of Qingkailing Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Qingkailing Injection Distributors
11.3 Qingkailing Injection Customer

12 WORLD FORECAST REVIEW FOR QINGKAILING INJECTION BY GEOGRAPHIC REGION

12.1 Global Qingkailing Injection Market Size Forecast by Region
  12.1.1 Global Qingkailing Injection Forecast by Region (2027-2032)
  12.1.2 Global Qingkailing Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Qingkailing Injection Forecast by Type (2027-2032)
12.7 Global Qingkailing Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Yabao Pharmaceutical Group Co., Ltd.
  13.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  13.1.2 Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.1.3 Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Yabao Pharmaceutical Group Co., Ltd. Main Business Overview
  13.1.5 Yabao Pharmaceutical Group Co., Ltd. Latest Developments
13.2 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd.
  13.2.1 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Company Information
  13.2.2 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.2.3 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Main Business Overview
  13.2.5 Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Latest Developments
13.3 Shanxi Taihang Pharmaceutical Co., Ltd.
  13.3.1 Shanxi Taihang Pharmaceutical Co., Ltd. Company Information
  13.3.2 Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.3.3 Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Shanxi Taihang Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Shanxi Taihang Pharmaceutical Co., Ltd. Latest Developments
13.4 Henan Province Shennong Pharmaceutical Co., Ltd.
  13.4.1 Henan Province Shennong Pharmaceutical Co., Ltd. Company Information
  13.4.2 Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.4.3 Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Henan Province Shennong Pharmaceutical Co., Ltd. Main Business Overview
  13.4.5 Henan Province Shennong Pharmaceutical Co., Ltd. Latest Developments
13.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd.
  13.5.1 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Company Information
  13.5.2 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.5.3 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Guangdong Leiyunshang Pharmaceutical Co., Ltd. Latest Developments
13.6 Shenwei Pharmaceutical Group Co., Ltd.
  13.6.1 Shenwei Pharmaceutical Group Co., Ltd. Company Information
  13.6.2 Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.6.3 Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Shenwei Pharmaceutical Group Co., Ltd. Main Business Overview
  13.6.5 Shenwei Pharmaceutical Group Co., Ltd. Latest Developments
13.7 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
  13.7.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Company Information
  13.7.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
  13.7.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Main Business Overview
  13.7.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Qingkailing Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Qingkailing Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2ml Each
Table 4. Major Players of 10ml Each
Table 5. Global Qingkailing Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Qingkailing Injection Sales Market Share by Type (2021-2026)
Table 7. Global Qingkailing Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Qingkailing Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Qingkailing Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Qingkailing Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Qingkailing Injection Sale Market Share by Application (2021-2026)
Table 12. Global Qingkailing Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Qingkailing Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Qingkailing Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Qingkailing Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Qingkailing Injection Sales Market Share by Company (2021-2026)
Table 17. Global Qingkailing Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Qingkailing Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Qingkailing Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Qingkailing Injection Producing Area Distribution and Sales Area
Table 21. Players Qingkailing Injection Products Offered
Table 22. Qingkailing Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Qingkailing Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Qingkailing Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Qingkailing Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Qingkailing Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Qingkailing Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Qingkailing Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Qingkailing Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Qingkailing Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Qingkailing Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Qingkailing Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Qingkailing Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Qingkailing Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Qingkailing Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Qingkailing Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Qingkailing Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Qingkailing Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Qingkailing Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Qingkailing Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Qingkailing Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Qingkailing Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Qingkailing Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Qingkailing Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Qingkailing Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Qingkailing Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Qingkailing Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Qingkailing Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Qingkailing Injection
Table 52. Key Market Challenges & Risks of Qingkailing Injection
Table 53. Key Industry Trends of Qingkailing Injection
Table 54. Qingkailing Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Qingkailing Injection Distributors List
Table 57. Qingkailing Injection Customer List
Table 58. Global Qingkailing Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Qingkailing Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Qingkailing Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Qingkailing Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Qingkailing Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Qingkailing Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Qingkailing Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Qingkailing Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Qingkailing Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Qingkailing Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Qingkailing Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Qingkailing Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Qingkailing Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Qingkailing Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Yabao Pharmaceutical Group Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 74. Yabao Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Yabao Pharmaceutical Group Co., Ltd. Main Business
Table 76. Yabao Pharmaceutical Group Co., Ltd. Latest Developments
Table 77. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 79. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Main Business
Table 81. Jilin Province Ji'an Yisheng Pharmaceutical Co., Ltd. Latest Developments
Table 82. Shanxi Taihang Pharmaceutical Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 84. Shanxi Taihang Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shanxi Taihang Pharmaceutical Co., Ltd. Main Business
Table 86. Shanxi Taihang Pharmaceutical Co., Ltd. Latest Developments
Table 87. Henan Province Shennong Pharmaceutical Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 89. Henan Province Shennong Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Henan Province Shennong Pharmaceutical Co., Ltd. Main Business
Table 91. Henan Province Shennong Pharmaceutical Co., Ltd. Latest Developments
Table 92. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 94. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Main Business
Table 96. Guangdong Leiyunshang Pharmaceutical Co., Ltd. Latest Developments
Table 97. Shenwei Pharmaceutical Group Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 99. Shenwei Pharmaceutical Group Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shenwei Pharmaceutical Group Co., Ltd. Main Business
Table 101. Shenwei Pharmaceutical Group Co., Ltd. Latest Developments
Table 102. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Basic Information, Qingkailing Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Product Portfolios and Specifications
Table 104. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Qingkailing Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Main Business
Table 106. Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Qingkailing Injection
Figure 2. Qingkailing Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Qingkailing Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Qingkailing Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Qingkailing Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Qingkailing Injection Sales Market Share by Country/Region (2025)
Figure 10. Qingkailing Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2ml Each
Figure 12. Product Picture of 10ml Each
Figure 13. Global Qingkailing Injection Sales Market Share by Type in 2026
Figure 14. Global Qingkailing Injection Revenue Market Share by Type (2021-2026)
Figure 15. Qingkailing Injection Consumed in Hospital
Figure 16. Global Qingkailing Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Qingkailing Injection Consumed in Clinic
Figure 18. Global Qingkailing Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Qingkailing Injection Consumed in Other
Figure 20. Global Qingkailing Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Qingkailing Injection Sale Market Share by Application (2025)
Figure 22. Global Qingkailing Injection Revenue Market Share by Application in 2026
Figure 23. Qingkailing Injection Sales by Company in 2026 (K Units)
Figure 24. Global Qingkailing Injection Sales Market Share by Company in 2026
Figure 25. Qingkailing Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Qingkailing Injection Revenue Market Share by Company in 2026
Figure 27. Global Qingkailing Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Qingkailing Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Qingkailing Injection Sales 2021-2026 (K Units)
Figure 30. Americas Qingkailing Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Qingkailing Injection Sales 2021-2026 (K Units)
Figure 32. APAC Qingkailing Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Qingkailing Injection Sales 2021-2026 (K Units)
Figure 34. Europe Qingkailing Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Qingkailing Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Qingkailing Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Qingkailing Injection Sales Market Share by Country in 2026
Figure 38. Americas Qingkailing Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Qingkailing Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Qingkailing Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Qingkailing Injection Sales Market Share by Region in 2026
Figure 46. APAC Qingkailing Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Qingkailing Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Qingkailing Injection Sales Market Share by Application (2021-2026)
Figure 49. China Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Qingkailing Injection Sales Market Share by Country in 2026
Figure 57. Europe Qingkailing Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Qingkailing Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Qingkailing Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Qingkailing Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Qingkailing Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Qingkailing Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Qingkailing Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Qingkailing Injection in 2026
Figure 74. Manufacturing Process Analysis of Qingkailing Injection
Figure 75. Industry Chain Structure of Qingkailing Injection
Figure 76. Channels of Distribution
Figure 77. Global Qingkailing Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Qingkailing Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Qingkailing Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Qingkailing Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Qingkailing Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Qingkailing Injection Revenue Market Share Forecast by Application (2027-2032)